Optimizing treatment and advanced multi-imaging response evaluation for very high risk prostate cancer (OPTIMAL)

Project: Research project

Project Details

StatusActive
Effective start/end date1/31/241/31/28

Funding

  • Pfizer Inc. (88556119)